NTLA
Intellia Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Intellia Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+2.46%
vs ±12.8% implied · ×0.19
shaded = implied · ▲▼ = realized
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | ARK Investment ManagementARK | $285.5M | 11.39% | +16.31% | |
| 2 | BlackRockBlackRockindex-like | $260.7M | 10.40% | +26.76% | |
| 3 | State StreetState Streetindex-like | $156.3M | 6.23% | +33.40% | |
| 4 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $124.1M | 4.95% | +17.82% | |
| 5 | D. E. ShawD. E. Shaw | $109.0M | 4.35% | +12.48% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $102.0M | 4.07% | +18.58% | |
| 7 | Two Sigma InvestmentsTwo Sigma | $88.6M | 3.53% | +11.25% | |
| 8 | FMRFMR | $80.8M | 3.22% | +130.89% | |
| 9 | RA Capital ManagementRA Capital Management | $76.6M | 3.06% | new | |
| 10 | Regeneron PharmaceuticalsRegeneron Pharmaceuticals | $62.7M | 2.50% | 0.00% | |
| 11 | Geode Capital ManagementGeodeindex-like | $61.4M | 2.45% | +27.34% | |
| 12 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $55.5M | 2.21% | +134.80% | |
| 13 | Sumitomo Mitsui Trust HoldingsSumitomo Mitsui Trust | $49.0M | 1.96% | +46.85% | |
| 14 | Nikko Asset Management AmericasNikko Asset Management Americas | $49.0M | 1.96% | +46.85% | |
| 15 | Dimensional Fund AdvisorsDimensional | $44.0M | 1.76% | +12.29% | |
| 16 | UBS GroupUBS | $41.4M | 1.65% | −24.91% | |
| 17 | Goldman Sachs GroupGoldman Sachs | $38.3M | 1.53% | +39.07% | |
| 18 | Susquehanna International GroupSusquehanna International | $36.5M | 1.45% | −20.28% | |
| 19 | Voloridge Investment ManagementVoloridge | $35.0M | 1.39% | +28.22% | |
| 20 | Contrarius Group HoldingsContrarius | $33.1M | 1.32% | +2.27% | |
| 21 | Jupiter Asset ManagementJupiter | $31.3M | 1.25% | +3.84% | |
| 22 | Morgan StanleyMorgan Stanley | $29.3M | 1.17% | −16.79% | |
| 23 | Armistice CapitalArmistice Capital | $25.4M | 1.01% | +346.43% | |
| 24 | Renaissance TechnologiesRenaissance Technologies | $23.7M | 0.94% | new | |
| 25 | Northern TrustNorthern Trustindex-like | $21.5M | 0.86% | +31.65% |
332 managers report $2.5B of Intellia Therapeutics on form 13F for the quarter ended Jun 30 '26. 30 of them hold 80% of it; ARK is largest at 11.39%.
Intellia Therapeutics, Inc.
12.45
−0.78 · −5.88%
post 12.39 −0.50%
Linked news
Expected move
Inputs8Q avg ±8.0%·×1.45·rich
straddle ±15.7%
spot 12.47exp Nov 20ATM strike 12ATM straddle 2.30IV 98%